Key clinical point: 18F-fluorodeoxyglucose PET/CT helps stage mantle cell lymphoma, sometimes altering management.
Major finding: Compared with CT alone, PET/CT led to upstaging in 17% of patients and down-staging in 2% of patients.
Study details: A two-center retrospective cohort study of 122 patients with mantle cell lymphoma.
Disclosures: No outside funding was disclosed. Dr. Albano reported having no relevant conflicts of interest.
Albano D et al. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e457-64.